Cell and gene therapy companies develop advanced treatments that modify, replace or engineer cells and genetic material to treat disease. The field is one of the fastest-growing areas of biotechnology and precision medicine.
This category includes companies working on:
Browse 144 UK cell and gene therapy companies below.
Cell-free enzymatic DNA manufacturing for genetic medicines
Touchlight is a contract development and manufacturing organisation producing synthetic DNA for genetic medicine applications using a cell-free enzymatic process. Its linear,…
Early phase clinical trial CRO based at London Bridge
Richmond Pharmacology is a contract research organisation specialising in early phase and first-in-human clinical trials for pharmaceutical and biotech companies. Operating from…
Cell therapy for vascular regeneration in ischaemic and wound healing conditions
VascVersa is a Belfast-based regenerative medicine company developing cell therapies for vascular regeneration and repair. The company's technology uses vasoreparative cells to…
Synthetic gene promoter platform for biologics and cell and gene therapy
SynGenSys is a synthetic biology company developing proprietary libraries of synthetic gene promoters and signal peptides designed to improve the yield, specificity, and…
Epigenetic reprogramming and senolytic therapeutics for cancer and ageing
199 Biotechnologies is a preclinical-stage biotechnology company developing epigenetic reprogramming and senolytic therapies targeting cancer and age-related disease. Its lead…
Personalised T cell therapy platform for solid tumour treatment
Swarm Oncology is a pre-clinical biotechnology company developing personalised T cell therapies for advanced solid cancers. Its platform combines in vivo immune priming with…
Human iPSC-based safety and genotoxicity testing for gene therapy vectors
TestAVec is a provider of in vitro safety testing services for gene therapy and viral vector products, serving academic researchers and industry developers. The company's human…
Mitochondrial transplantation platform to restore cellular energy and regeneration
Recondria Therapeutics is a developer of a mitochondrial transplantation platform designed to restore cellular energy, accelerate tissue recovery and support regenerative…
GMP lentiviral and retroviral vector design and manufacture for CGT
ViroCell Biologics is a specialist contract development and manufacturing organisation providing GMP design and manufacture of lentiviral and retroviral vectors for cell and gene…
Single-cell cloning and clone characterisation instruments for biopharma
Advanced Instruments is an instrumentation company developing and manufacturing products for the upstream cell line development workflow in biopharmaceutical and cell and gene…
GLP/GMP biosafety testing centre of excellence for biologics and vaccines
SGS Vitrology is a biosafety testing contract research organisation operating from a 3,100m² GLP and GMP-accredited facility in Glasgow. The site serves as SGS's global centre of…
University of Oxford GMP facility for clinical-grade biologics
The Clinical BioManufacturing Facility is the University of Oxford's GMP-licensed manufacturing facility, producing biological investigational medicinal products for early-phase…